Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study

被引:110
作者
Rovaris, M
Agosta, F
Sormani, MP
Inglese, M
Martinelli, V
Comi, G
Filippi, M
机构
[1] Ist Sci San Raffaele, Dept Neurosci, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Dept Neurosci, Clin Trial Unit, I-20132 Milan, Italy
[3] Univ Milan, Osped San Raffaele, I-20132 Milan, Italy
关键词
multiple sclerosis; MRI; magnetization transfer MRI; clinical evolution;
D O I
10.1093/brain/awg232
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The correlation between conventional MRI lesion load accumulation and multiple sclerosis clinical evolution is only modest. The assessment of brain parenchymal volume and of its changes over time may provide adjunctive MRI markers reflecting the more disabling aspects of multiple sclerosis pathology. Magnetization transfer (MT) MRI is sensitive to 'occult' multiple sclerosis-related brain damage and might also contribute to overcome the clinical/MRI paradox. In this study, we assessed the value of conventional and MT MRI-derived metrics in predicting the medium-term clinical evolution of patients with different multiple sclerosis phenotypes. We studied 73 patients, with relapsing-remitting multiple sclerosis (n=34), secondary progressive multiple sclerosis (n=19) and clinically isolated syndromes suggestive of multiple sclerosis (n=20), and 16 healthy subjects. Brain dual-echo, T(1)-weighted (only in patients) and MT MRI scans were obtained at baseline and after 12 months. T(2)-hyperintense and T(1)-hypointense lesion volumes, normalized brain volume and average lesion MT ratio (MTR) were measured. MTR histograms from the whole brain tissue were also obtained. Clinical multiple sclerosis evolution and neurological disability were re-assessed in all patients after a median follow-up of 4.5 years. A multivariate analysis was performed to establish which clinical and MRI-derived variables were significant predictors of neurological deterioration at the end of the study period. At the end of follow-up, 34 patients showed significant neurological deterioration. The final multivariable model included average brain MTR percentage change after one year [P=0.02, odds ratio (OR)= 0.86]and baseline T(2)-hyperintense lesion volume (P=0.04, OR=1.04) as independent predictors of medium-term disability accumulation (r(2)=0.23). In this cohort of patients, abnormal values of average brain MTR changes showed a relatively high specificity (76.9%) and positive predictive value (59.1%) for Expanded Disability Status Scale score deterioration in individual cases. In patients with multiple sclerosis, a comprehensive estimation of the short-term changes of both conventional and MT MRI-detectable lesion burden might provide useful prognostic information for the medium-term clinical disease evolution.
引用
收藏
页码:2323 / 2332
页数:10
相关论文
共 40 条
  • [1] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
    Brex, PA
    Ciccarelli, O
    O'Riordan, JI
    Sailer, M
    Thompson, AJ
    Miller, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) : 158 - 164
  • [2] DUQUETTE P, 1995, NEUROLOGY, V45, P1277
  • [3] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    [J]. LANCET, 1998, 352 (9139) : 1498 - 1504
  • [4] MRI techniques to monitor MS evolution - The present and the future
    Filippi, M
    Grossman, RI
    [J]. NEUROLOGY, 2002, 58 (08) : 1147 - 1153
  • [5] Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
    Filippi, M
    Iannucci, G
    Tortorella, C
    Minicucci, L
    Horsfield, MA
    Colombo, B
    Sormani, MP
    Comi, G
    [J]. NEUROLOGY, 1999, 52 (03) : 588 - 594
  • [6] Magnetization transfer imaging to monitor the evolution of MS - A 1-year follow-up study
    Filippi, M
    Inglese, M
    Rovaris, M
    Sormani, MP
    Horsfield, MA
    Iannucci, G
    Colombo, B
    Comi, G
    [J]. NEUROLOGY, 2000, 55 (07) : 940 - 946
  • [7] Interferons in relapsing remitting multiple sclerosis: a systematic review
    Filippini, G
    Munari, L
    Incorvaia, B
    Ebers, GC
    Polman, C
    D'Amico, R
    Rice, GPA
    [J]. LANCET, 2003, 361 (9357) : 545 - 552
  • [8] Eight-year follow-up study of brain atrophy in patients with MS
    Fisher, E
    Rudick, RA
    Simon, JH
    Cutter, G
    Baier, M
    Lee, JC
    Miller, D
    Weinstock-Guttman, B
    Mass, MK
    Dougherty, DS
    Simonian, NA
    [J]. NEUROLOGY, 2002, 59 (09) : 1412 - 1420
  • [9] The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS
    Inglese, M
    van Waesberghe, JHTM
    Rovaris, M
    Beckmann, K
    Barkhof, F
    Hahn, D
    Kappos, L
    Miller, DH
    Polman, C
    Pozzilli, C
    Thompson, AJ
    Yousry, TA
    Wagner, K
    Comi, G
    Filippi, M
    [J]. NEUROLOGY, 2003, 60 (05) : 853 - 860
  • [10] Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Herndon, RM
    Richert, JR
    Salazar, AM
    Fischer, JS
    Goodkin, DE
    Granger, CV
    Simon, JH
    Alam, JJ
    Bartoszak, DM
    Bourdette, DN
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Priore, RL
    Pullicino, PM
    Scherokman, BJ
    WeinstockGuttman, B
    Whitman, RH
    Baird, WC
    Fillmore, M
    Bona, LM
    ColonRuiz, ME
    Nadine, BS
    Donovan, A
    Bennett, S
    Kieffer, YM
    Umhauer, MA
    Miller, CE
    Kilic, AK
    Sargent, EL
    Schachter, M
    Shucard, DW
    Weider, V
    Catalano, BA
    Cervi, JM
    Czekay, C
    Farrell, JL
    Filippini, JS
    Matyas, RC
    Michienzi, KE
    Ito, M
    OMalley, JA
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (03) : 285 - 294